Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized sellers, manufacturers and distributors of copycat versions of the medicine. In lawsuits filed Wednesday in the U.S. District Court for the Northern District of California, Lilly accused the sites...